Users can pick binding pockets, see predicted receptor activity and fold designs with one or more engines. Folding costs $0.10 per peptide.
Recap by typeshit. Post by Andre Watson 🧬 on X.
A new GLP-1 described as stronger than current options is being tested in trials, and researchers lay out what people should understand about it.
A SURPASS-4 analysis at ASN Kidney Week 2026 found rapid kidney decline in 5% on tirzepatide versus 13% on insulin glargine, with the biggest gains in high protein groups.
Among 208,970 matched adults with type 2 diabetes, GLP-1 starters had 0.15% new diagnoses versus 0.10% on DPP-4 drugs. Authors call it a signal needing confirmation.
Researchers used AI to identify fungal peptides that taste salty or boost saltiness, aimed at cutting sodium in food. A food science find rather than a drug story.
A Facebook post covers what GLP-1 weight loss drugs can mean for people booked in for a gastroscopy or colonoscopy.
Researchers found about three to four extra cases of ischemic optic neuropathy per 10,000 patients over 18 months, mostly in men and people aged 50 to 65.
Loading…